A lyophilised peptide is a dry cake at the bottom of a vial, and it does nothing until it is dissolved. Reconstitution is that step: adding a measured volume of sterile liquid to turn the powder into a solution that can be measured and drawn. The arithmetic of how much liquid to add, and what concentration results, belongs to the reconstitution calculator; this article covers the part the calculator does not, which is the physical and chemical procedure itself. It is a reference for handling research peptides, not medical or dosing advice, and it says nothing about how much of any compound a person should use.
What reconstitution actually means
Peptides are shipped freeze-dried because water is what degrades them. Most of the reactions that break a peptide down, hydrolysis, deamidation, oxidation, need water to proceed, so removing it by lyophilisation slows the chemistry from a timescale of days or weeks to one of months or years. Reconstitution reverses that protection deliberately: adding a diluent puts the molecule back into solution so it can be handled, and in the same motion restarts the degradation clock. The diluent, the gentleness of the technique, and the storage temperature that follow are all about managing that trade-off between a usable solution and a molecule once again in its least stable state. The companion reference on how a reconstituted peptide degrades over time covers those pathways in detail.
Choosing the diluent
The two fluids used most often are sterile water for injection and bacteriostatic water for injection, and the single difference between them decides how the vial can be treated. Sterile water contains no preservative and is intended for a single use. Bacteriostatic water is the same water for injection preserved with 0.9% (9 mg/mL) benzyl alcohol, per the labelled product description, which suppresses microbial growth and lets a container be entered more than once. That preservative is the entire reason a multi-dose vial has a usable life after the first puncture. It also carries costs: benzyl alcohol can destabilise some sequences and is unsuitable for certain uses, which is why the diluent deserves the same scrutiny as the powder. The diluent side of peptide quality sets out the grade, sterility, pH, and container rules in full. Choosing between the two is a quality decision, not a dosing one: it turns on how many times the vial will be entered and whether the peptide tolerates a preservative.
The step-by-step procedure
The goal is to get the powder into solution without contaminating it and without subjecting the molecule to mechanical stress. In outline:
- Work clean. Prepare on a clean surface with clean hands. Wipe the rubber stopper of both the peptide vial and the diluent vial with a fresh alcohol swab and let them dry, so the needle passes through a disinfected surface each time.
- Draw the diluent. Using a sterile syringe, withdraw the volume of diluent you have decided on. That volume is a concentration choice, addressed below, not a fixed number.
- Add it slowly, down the wall. Angle the needle so the diluent runs down the inside glass wall of the peptide vial rather than jetting directly onto the cake. A slow stream against the wall avoids forcing liquid through the powder under pressure.
- Swirl, never shake. Roll or swirl the vial gently until the cake dissolves. Do not shake it and do not invert it hard. A well-lyophilised cake usually dissolves quickly; a slow one needs a little more patience, not more force.
- Let it dissolve fully and inspect. The finished solution should be clear and free of visible particles. Cloudiness, floating material, or a precipitate means something is wrong, either undissolved or aggregated peptide, and that vial should not be used.
The sequence is unremarkable when it goes right. Its value is entirely in the two things it prevents: contamination from a non-sterile surface, and aggregation from rough handling.
Why gentle technique matters
The instruction to swirl rather than shake is not fussiness; it is the one point in the procedure where technique changes the molecule. Peptides aggregate, meaning individual molecules associate into dimers, higher-order clusters, and eventually visible particles, and one of the strongest triggers is exposure to a hydrophobic surface. The air-water interface is such a surface. A peer-reviewed review of the physical stability of peptide therapeutics documents surface-induced aggregation at air-water interfaces for peptides including insulin and amyloid-β, and notes that agitation is used deliberately in the laboratory to accelerate aggregation studies. Shaking a vial does exactly that by accident: it whips air into the liquid, multiplies the air-water interface, and foams the solution. Foam is visible evidence that the peptide is being spread across fresh hydrophobic surface. Aggregated peptide is not something a certificate on the original powder can warn you about, because the damage happens after the vial leaves the laboratory, in a few seconds of over-vigorous mixing.
Working out the concentration
Concentration is the one number reconstitution produces, and it follows a single relationship: concentration equals mass divided by volume. The mass is fixed by what is in the vial; the volume is what you add. A peptide reconstituted in a small volume of diluent is concentrated; in a larger volume it is dilute. Adding more water never changes how much peptide is present, only how much liquid it is spread through, so the diluent volume is a concentration choice and nothing more. Turning that concentration into a volume for a given amount is arithmetic best handed to the peptide reconstitution calculator, which converts vial amount, diluent volume, and target amount into a syringe reading and shows each step. This article deliberately stops at the concept: how much of any compound to prepare or use is a clinical question, outside the scope of a handling reference.
Storage and in-use life after reconstitution
A reconstituted vial has a much shorter usable life than the sealed lyophilised one it came from, because the protection of the dry state is gone. Three variables govern how long it holds. The first is temperature: reconstituted peptides are kept cold, typically 2–8 °C, and warm storage shortens their life sharply. The second is the preservative: a vial reconstituted with bacteriostatic water is bounded by the 28-day in-use ceiling that applies to opened multi-dose containers. CDC injection-safety guidance states that a multi-dose vial should be dated and discarded within 28 days of first puncture unless the manufacturer specifies otherwise, and that this in-use date can never run past the printed expiry. The third is freeze-thaw: repeatedly freezing and thawing a reconstituted solution is its own stressor, because each cycle promotes aggregation, so where a solution must be held for a long time, single-use frozen aliquots are preferred to thawing one stock again and again. The full treatment of storage and shelf life works through the cold-chain and freeze-thaw questions in depth.
What testing has to do with it
Reconstitution is a physical procedure, and no physical procedure can improve what is already in the vial. If the starting powder is mislabelled, underfilled, or impure, flawless aseptic technique produces a clear, sterile solution of the wrong thing at the wrong concentration. Technique controls contamination and aggregation; it cannot control identity or purity, and it cannot detect a problem that was set before the vial was sealed. Those are the questions independent analysis answers before reconstitution is ever considered: whether the molecule is what the label claims, and how much of it is really present. Knowing how to read a certificate of analysis, and what a purity percentage does and does not measure, is what makes the concentration you calculate mean anything. A perfectly reconstituted vial of an unverified powder is still an unverified powder in solution.
Technique, in one paragraph
Reconstitution turns a stable dry peptide into a usable but less stable solution. Choose the diluent for how the vial will be used: sterile water for a single entry, bacteriostatic water for a preserved multi-dose vial. Swab the stoppers, add the diluent slowly down the glass wall, and swirl gently until clear, never shaking, because foam drives aggregation. The volume you add sets the concentration and nothing else; let the calculator turn that into a draw. Store the result cold, respect the 28-day ceiling on a bacteriostatic vial, and avoid repeated freeze-thaw. And remember what the procedure cannot do: it cannot make an unverified powder into a verified one. That happens in the laboratory, before any water is added.